These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39242030)

  • 1. Adapting outside the box: Simulation-free MR-guided stereotactic ablative radiotherapy for prostate cancer.
    de Leon J; Jelen U; Carr M; Crawford D; Picton M; Tran C; McKenzie L; Peng V; Twentyman T; Jameson MG; Batumalai V
    Radiother Oncol; 2024 Nov; 200():110527. PubMed ID: 39242030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
    Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
    BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial.
    Zapatero A; Castro P; Roch M; Carnero PR; Carroceda S; Rosciupchin AES; Hernández SH; Cogorno L; Iturriaga AG; García DB
    Radiat Oncol; 2024 May; 19(1):54. PubMed ID: 38702761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria.
    Persson E; Jamtheim Gustafsson C; Ambolt P; Engelholm S; Ceberg S; Bäck S; Olsson LE; Gunnlaugsson A
    Radiat Oncol; 2020 Apr; 15(1):77. PubMed ID: 32272943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
    Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
    Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
    Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases.
    Werensteijn-Honingh AM; Kroon PS; Winkel D; Aalbers EM; van Asselen B; Bol GH; Brown KJ; Eppinga WSC; van Es CA; Glitzner M; de Groot-van Breugel EN; Hackett SL; Intven M; Kok JGM; Kontaxis C; Kotte AN; Lagendijk JJW; Philippens MEP; Tijssen RHN; Wolthaus JWH; Woodings SJ; Raaymakers BW; Jürgenliemk-Schulz IM
    Radiother Oncol; 2019 May; 134():50-54. PubMed ID: 31005224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose tracking assessment for magnetic resonance guided adaptive radiotherapy of rectal cancers.
    Xin X; Tang B; Wu F; Lang J; Li J; Wang X; Liu M; Zhang Q; Liao X; Yang F; Orlandini LC
    Radiat Oncol; 2024 Sep; 19(1):114. PubMed ID: 39218934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions - dosimetric impact and how to detect its extent in advance.
    Buchele C; Renkamp CK; Regnery S; Behnisch R; Rippke C; Schlüter F; Hoegen-Saßmannshausen P; Debus J; Hörner-Rieber J; Alber M; Klüter S
    Radiat Oncol; 2024 Jun; 19(1):80. PubMed ID: 38918828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes.
    Mazzola R; Cuccia F; Figlia V; Rigo M; Nicosia L; Giaj-Levra N; Ricchetti F; Vitale C; Mantoan B; Di Paola G; De Simone A; Gurrera D; Sicignano G; Naccarato S; Ruggieri R; Alongi F
    Radiol Med; 2021 Jul; 126(7):989-997. PubMed ID: 33835309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
    Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
    Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
    Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of treatment workflow for 0.35T MR-Linac system.
    Behzadipour M; Palta J; Ma T; Yuan L; Kim S; Kirby S; Torkelson L; Baker J; Koenig T; Khalifa MA; Hawranko R; Richeson D; Fields E; Weiss E; Song WY
    J Appl Clin Med Phys; 2024 Aug; 25(8):e14393. PubMed ID: 38742819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis.
    Tyagi N; Fontenla S; Zhang J; Cloutier M; Kadbi M; Mechalakos J; Zelefsky M; Deasy J; Hunt M
    Phys Med Biol; 2017 Apr; 62(8):2961-2975. PubMed ID: 27983520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
    Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
    Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.
    Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):206-13. PubMed ID: 27511856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy.
    Nachbar M; Lo Russo M; Gani C; Boeke S; Wegener D; Paulsen F; Zips D; Roque T; Paragios N; Thorwarth D
    Z Med Phys; 2024 May; 34(2):197-207. PubMed ID: 37263911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.